Lophius Bio Receives $2.8M Financing, Names New CEO | GenomeWeb

NEW YORK (GenomeWeb) – Lophius Biosciences today announced it received a €2.0 million ($2.8 million) investment to fund clinical studies of its flagship product and to develop new products.

The firm also announced a new CEO and changes to its board.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.